Mr. Saud Saqib Rahman, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 25 Riverside Dr Ste 2, Pine Brook, NJ 07058 Phone: 201-599-9044 Fax: 201-599-9066 |
Amal Aly, MD., PHD Pathology - Molecular Genetic Pathology Medicare: Not Enrolled in Medicare Practice Location: 25 Riverside Dr Ste 2, Pine Brook, NJ 07058 Phone: 888-599-5227 |
Dr. Sherif A Nasr, Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 25 Riverside Dr Ste 2, Pine Brook, NJ 07058 Phone: 201-599-9044 Fax: 201-599-9066 |
News Archive
Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.
When people hear voices, it is whether those voices fit or are at odds with their life goals and values that governs whether they find them distressing.
Over the last couple of decades, significant reductions in vehicle crash-related child fatalities have been attributed to advances in legislation, public safety campaigns, and engineering. However, less is known about nontraffic injuries and fatalities (occurring primarily in driveways and parking lots) to children in and around motor vehicles.
New research presented at the British Pharmaceutical Conference (BPC) in Manchester shows that a new gel for under the eyelid could provide an innovative way of delivering drugs to treat age-related retinal diseases such as wet macular degeneration - potentially making some invasive eye injections a thing of the past.
Gene therapy could offer a new, long-lasting way to treat Parkinson's disease, research results announced Tuesday 15 July at FENS 2008 suggest. Dr Deniz Kirik of the University of Lund in Sweden has been using viruses to insert a new combination of genes into animals' brains, where they help produce the dopamine that is lacking in Parkinson's disease. The results suggest the treatment is very effective in animal models for several months, possibly years.
› Verified 1 days ago